國立高雄大學圖資館 |

Language: English

Back

Nanoparticles in the management of atherosclerosisa machine-generated literature overview /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Nanoparticles in the management of atherosclerosisedited by Sourabh Mehta.
Reminder of title:	a machine-generated literature overview /
other author:	Mehta, Sourabh.
Published:	Cham :Springer Nature Switzerland :2025.
Description:	xvii, 419 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	AtherosclerosisTreatment.
Online resource:	https://doi.org/10.1007/978-3-031-46752-3
ISBN:	9783031467523$q(electronic bk.)

Nanoparticles in the management of atherosclerosisa machine-generated literature overview /
Nanoparticles in the management of atherosclerosisa machine-generated literature overview /[electronic resource] :edited by Sourabh Mehta. - Cham :Springer Nature Switzerland :2025. - xvii, 419 p. :ill. (some col.), digital ;24 cm.

Introduction to atherosclerosis -- Introduction to nanoparticles, synthesis characterization and clinical status -- Nanoparticles used in diagnosis of atherosclerosis -- Theranostic-Nanoparticles used for atherosclerosis.

The book's primary objective is to introduce the pathology and physiology atherosclerosis in brief, and its diagnosis and treatment. Atherosclerosis is an inflammatory disease of the arterial wall. An advanced understanding of atherosclerosis shows that it leads to myocardial infarction and other cardiovascular diseases, taking 17 million people every year worldwide. The literature suggests that atherosclerosis is an ancient disease and is still a long-standing health problem globally. Hence early diagnosis and treatment of atherosclerosis are crucial to solving long-standing health issues. This book provides a systemic summary of recent literature focusing on disease pathology, advancement in diagnosis and therapies. Recently, nanoparticles performing dual roles as diagnostic and therapeutic agents have been keenly interested. However, the nanoparticle has yet to reach the clinic. Understanding the role of biomaterials in formulations and existing strategies is critical when developing novel formulations and working on translation to clinical settings. The book provides a systematic biomaterial-based summary of the literature, methods used to formulate nanoparticles, and their scale-up potential. Another key objective of the book is to motivate the reader to conduct research on theranostic nanoparticles to treat atherosclerosis and put us one step closer to solving a long-standing health problem-atherosclerosis. The auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the external editor. The editor of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that the auto-summaries consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage.

ISBN: 9783031467523$q(electronic bk.)

Standard No.: 10.1007/978-3-031-46752-3doiSubjects--Topical Terms:

531320
Atherosclerosis
--Treatment.

LC Class. No.: RC692

Dewey Class. No.: 616.136

Nanoparticles in the management of atherosclerosisa machine-generated literature overview /
LDR:03357nmm a2200349 a 4500 001 679437
003 DE-He213
005 20250129204218.0
006 m d
007 cr nn 008maaau
008 251110s2025 sz s 0 eng d
020 $a 9783031467523$q(electronic bk.)
020 $a 9783031467516$q(paper)
024 7 $a 10.1007/978-3-031-46752-3 $2 doi
035 $a 978-3-031-46752-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC692
072 7 $a TBN $2 bicssc
072 7 $a TCB $2 bicssc
072 7 $a TEC027000 $2 bisacsh
072 7 $a TBN $2 thema
072 7 $a TCB $2 thema
082 0 4 $a 616.136 $2 23
090 $a RC692 $b .N186 2025
245 0 0 $a Nanoparticles in the management of atherosclerosis $h [electronic resource] : $b a machine-generated literature overview / $c edited by Sourabh Mehta.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2025.
300 $a xvii, 419 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Introduction to atherosclerosis -- Introduction to nanoparticles, synthesis characterization and clinical status -- Nanoparticles used in diagnosis of atherosclerosis -- Theranostic-Nanoparticles used for atherosclerosis.
520 $a The book's primary objective is to introduce the pathology and physiology atherosclerosis in brief, and its diagnosis and treatment. Atherosclerosis is an inflammatory disease of the arterial wall. An advanced understanding of atherosclerosis shows that it leads to myocardial infarction and other cardiovascular diseases, taking 17 million people every year worldwide. The literature suggests that atherosclerosis is an ancient disease and is still a long-standing health problem globally. Hence early diagnosis and treatment of atherosclerosis are crucial to solving long-standing health issues. This book provides a systemic summary of recent literature focusing on disease pathology, advancement in diagnosis and therapies. Recently, nanoparticles performing dual roles as diagnostic and therapeutic agents have been keenly interested. However, the nanoparticle has yet to reach the clinic. Understanding the role of biomaterials in formulations and existing strategies is critical when developing novel formulations and working on translation to clinical settings. The book provides a systematic biomaterial-based summary of the literature, methods used to formulate nanoparticles, and their scale-up potential. Another key objective of the book is to motivate the reader to conduct research on theranostic nanoparticles to treat atherosclerosis and put us one step closer to solving a long-standing health problem-atherosclerosis. The auto-summaries have been generated by a recursive clustering algorithm via the Dimensions Auto-summarizer by Digital Science handled by Subject Matter Experts and the external editor. The editor of this book selected which SN content should be auto-summarized and decided its order of appearance. Please be aware that the auto-summaries consist of original sentences, but are not representative of its original paper, since we do not show the full length of the publication. Please note that only published SN content is represented here, and that machine-generated books are still at an experimental stage.
650 0 $a Atherosclerosis $x Treatment. $3 531320
650 0 $a Nanoparticles $x Therapeutic use. $3 648588
650 0 $a Nanomedicine. $3 273406
650 0 $a Nanobiotechnology. $3 679667
650 0 $a Cardiovascular system. $3 229458
650 0 $a Physiology. $3 192980
650 0 $a Cardiology. $3 273804
650 0 $a Nanotechnology. $3 193873
650 0 $a Molecular biology. $3 188737
650 2 4 $a Cardiovascular Physiology. $3 281783
650 2 4 $a Molecular Biology. $3 189026
700 1 $a Mehta, Sourabh. $3 992383
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-46752-3
950 $a Chemistry and Materials Science (SpringerNature-11644)